On the public citation graph

Microtubule‐targeting agents for cancer treatment: Seven binding sites and three strategies

https://doi.org/10.1002/mog2.46
0 signed · 283 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jama.2017.3438openalex-snapshot
Selumetinib Plus Docetaxel Compared With Docetaxel Alone and Progression-Free Survival in Patients With KRAS -Mutant Advanced Non–Small Cell Lung Cancer
inferredcites →https://doi.org/10.1002/adma.202002902openalex-snapshot
Tubulin‐Based Nanotubes as Delivery Platform for Microtubule‐Targeting Agents
inferredcites →https://doi.org/10.1002/anie.201307749openalex-snapshot
Structural Basis of Microtubule Stabilization by Laulimalide and Peloruside A
inferredcites →https://doi.org/10.1002/anie.201601931openalex-snapshot
Emerging Targets in Photopharmacology
inferredcites →https://doi.org/10.1002/anie.202114614openalex-snapshot
Photoswitchable Epothilone‐Based Microtubule Stabilisers Allow GFP‐Imaging‐Compatible, Optical Control over the Microtubule Cytoskeleton**
inferredcites →https://doi.org/10.1002/cac2.12379openalex-snapshot
A phase Ib/II study of fruquintinib in combination with paclitaxel as the second‐line therapy for advanced gastric cancer
inferredcites →https://doi.org/10.1002/cai2.8openalex-snapshot
Expert consensus on the clinical application of antibody‐drug conjugates in the treatment of malignant tumors (2021 edition)
inferredcites →https://doi.org/10.1002/chem.202103520openalex-snapshot
Maytansinol Derivatives: Side Reactions as a Chance for New Tubulin Binders
inferredcites →https://doi.org/10.1002/cmdc.201100410openalex-snapshot
Nocodazole is a High‐Affinity Ligand for the Cancer‐Related Kinases ABL, c‐KIT, BRAF, and MEK
inferredcites →https://doi.org/10.1002/dneu.22745openalex-snapshot
Alpha‐ and beta‐tubulin isotypes are differentially expressed during brain development
inferredcites →https://doi.org/10.1002/jcp.28967openalex-snapshot
Potential drugs used in the antibody–drug conjugate (ADC) architecture for cancer therapy
inferredcites →https://doi.org/10.1002/jcp.28978openalex-snapshot
Microtubule‐interfering agents, spindle defects, and interkinetochore tension
inferredcites →https://doi.org/10.1002/med.20242openalex-snapshot
Drugs that target dynamic microtubules: A new molecular perspective
inferredcites →https://doi.org/10.1002/med.21378openalex-snapshot
Microtubule‐Binding Proteins as Promising Biomarkers of Paclitaxel Sensitivity in Cancer Chemotherapy
inferredcites →https://doi.org/10.1002/med.21877openalex-snapshot
Strategies for designing proteolysis targeting chimaeras (PROTACs)
inferredcites →https://doi.org/10.1006/jmbi.2001.5077openalex-snapshot
Refined structure of αβ-tubulin at 3.5 Å resolution 1 1Edited by I. A. Wilson
inferredcites →https://doi.org/10.1007/s00280-019-03884-5openalex-snapshot
Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review
inferredcites →https://doi.org/10.1007/s10557-021-07239-2openalex-snapshot
Colchicine-Containing Nanoparticles Attenuates Acute Myocardial Infarction Injury by Inhibiting Inflammation
inferredcites →https://doi.org/10.1007/s10637-011-9734-1openalex-snapshot
Anti-neoplastic agent thymoquinone induces degradation of α and β tubulin proteins in human cancer cells without affecting their level in normal human fibroblasts
inferredcites →https://doi.org/10.1007/s10637-015-0232-8openalex-snapshot
Inhibition of human vascular endothelial cell migration and capillary-like tube formation by the microtubule-stabilizing agent peloruside A
inferredcites →https://doi.org/10.1007/s10822-019-00208-wopenalex-snapshot
Unravelling the covalent binding of zampanolide and taccalonolide AJ to a minimalist representation of a human microtubule
inferredcites →https://doi.org/10.1007/s12185-020-02820-1openalex-snapshot
Phase I study of brentuximab vedotin (SGN-35) in Japanese children with relapsed or refractory CD30-positive Hodgkin’s lymphoma or systemic anaplastic large cell lymphoma
inferredcites →https://doi.org/10.1007/s13205-023-03636-6openalex-snapshot
Vinca alkaloids as a potential cancer therapeutics: recent update and future challenges
inferredcites →https://doi.org/10.1007/s13346-015-0226-2openalex-snapshot
Systemic delivery of nanoparticle formulation of novel tubulin inhibitor for treating metastatic melanoma
inferredcites →https://doi.org/10.1007/s40265-023-01834-3openalex-snapshot
Mirvetuximab Soravtansine: First Approval
inferredcites →https://doi.org/10.1016/j.bbagen.2022.130276openalex-snapshot
Acetylation and phosphorylation processes modulate Tau’s binding to microtubules: A molecular dynamics study
inferredcites →https://doi.org/10.1016/j.bbamcr.2022.119241openalex-snapshot
Direct and indirect effects of tubulin post-translational modifications on microtubule stability: Insights and regulations
inferredcites →https://doi.org/10.1016/j.bbcan.2022.188777openalex-snapshot
Combination of microtubule targeting agents with other antineoplastics for cancer treatment
inferredcites →https://doi.org/10.1016/j.bbrc.2009.08.009openalex-snapshot
The microtubule-targeting agent T0070907 induces proteasomal degradation of tubulin
inferredcites →https://doi.org/10.1016/j.bbrc.2019.02.064openalex-snapshot
Molecular mechanism of crolibulin in complex with tubulin provides a rationale for drug design
inferredcites →https://doi.org/10.1016/j.bbrc.2020.11.082openalex-snapshot
High-resolution X-ray structure of three microtubule-stabilizing agents in complex with tubulin provide a rationale for drug design
inferredcites →https://doi.org/10.1016/j.bbrc.2021.05.071openalex-snapshot
C3 ester side chain plays a pivotal role in the antitumor activity of Maytansinoids
inferredcites →https://doi.org/10.1016/j.bioorg.2022.105848openalex-snapshot
Advances and perspectives of proteolysis targeting chimeras (PROTACs) in drug discovery
inferredcites →https://doi.org/10.1016/j.bioorg.2022.105915openalex-snapshot
Cytotoxicity of phenylpironetin analogs and the metabolic fate of pironetin and phenylpironetin
inferredcites →https://doi.org/10.1016/j.bmcl.2019.05.042openalex-snapshot
Revisiting microtubule targeting agents: α-Tubulin and the pironetin binding site as unexplored targets for cancer therapeutics
inferredcites →https://doi.org/10.1016/j.chembiol.2004.03.028openalex-snapshot
The Anticancer Natural Product Pironetin Selectively Targets Lys352 of α-Tubulin
inferredcites →https://doi.org/10.1016/j.cmet.2021.05.009openalex-snapshot
Mechano-induced cell metabolism promotes microtubule glutamylation to force metastasis
inferredcites →https://doi.org/10.1016/j.cub.2007.08.063openalex-snapshot
Straight GDP-Tubulin Protofilaments Form in the Presence of Taxol
inferredcites →https://doi.org/10.1016/j.ddtec.2019.01.002openalex-snapshot
PROteolysis TArgeting Chimeras (PROTACs) — Past, present and future
inferredcites →https://doi.org/10.1016/j.devcel.2018.08.014openalex-snapshot
Human β-Tubulin Isotypes Can Regulate Microtubule Protofilament Number and Stability
inferredcites →https://doi.org/10.1016/j.drudis.2021.12.001openalex-snapshot
Molecular interactions at the colchicine binding site in tubulin: An X-ray crystallography perspective
inferredcites →https://doi.org/10.1016/j.drup.2020.100742openalex-snapshot
Taxanes in cancer treatment: Activity, chemoresistance and its overcoming
inferredcites →https://doi.org/10.1016/j.ejcb.2020.151075openalex-snapshot
Microtubule-targeting agents and their impact on cancer treatment
inferredcites →https://doi.org/10.1016/j.ejmech.2011.02.011openalex-snapshot
Design and synthesis of pironetin analogues with simplified structure and study of their interactions with microtubules
inferredcites →https://doi.org/10.1016/j.ejmech.2014.09.051openalex-snapshot
Recent developments in tubulin polymerization inhibitors: An overview
inferredcites →https://doi.org/10.1016/j.ejmech.2017.11.012openalex-snapshot
Photoresponsive azo-combretastatin A-4 analogues
inferredcites →https://doi.org/10.1016/j.ejmech.2019.111583openalex-snapshot
Benzothienoquinazolinones as new multi-target scaffolds: Dual inhibition of human Topoisomerase I and tubulin polymerization
inferredcites →https://doi.org/10.1016/j.isci.2020.101511openalex-snapshot
The Mechanism of Tubulin Assembly into Microtubules: Insights from Structural Studies
inferredcites →https://doi.org/10.1016/j.jacep.2023.02.003openalex-snapshot
Prophylactic Colchicine After Radiofrequency Ablation of Atrial Fibrillation
inferredcites →https://doi.org/10.1016/j.jmb.2016.06.023openalex-snapshot
Pironetin Binds Covalently to αCys316 and Perturbs a Major Loop and Helix of α-Tubulin to Inhibit Microtubule Formation
inferredcites →https://doi.org/10.1016/j.jmb.2017.01.001openalex-snapshot
Insights into the Distinct Mechanisms of Action of Taxane and Non-Taxane Microtubule Stabilizers from Cryo-EM Structures
inferredcites →https://doi.org/10.1016/j.kjms.2015.12.006openalex-snapshot
Anticancer effects of clinically acceptable colchicine concentrations on human gastric cancer cell lines
inferredcites →https://doi.org/10.1016/j.molmed.2007.07.001openalex-snapshot
From traditional Chinese medicine to rational cancer therapy
inferredcites →https://doi.org/10.1016/j.semarthrit.2015.06.013openalex-snapshot
Colchicine—Update on mechanisms of action and therapeutic uses
inferredcites →https://doi.org/10.1016/j.sjbs.2022.103436openalex-snapshot
Role of motor proteins in human cancers
inferredcites →https://doi.org/10.1016/j.taap.2021.115534openalex-snapshot
Microtubule and tubulin binding and regulation of microtubule dynamics by the antibody drug conjugate (ADC) payload, monomethyl auristatin E (MMAE): Mechanistic insights into MMAE ADC peripheral neuropathy
inferredcites →https://doi.org/10.1016/j.tcb.2015.08.009openalex-snapshot
Regulation of Microtubule Growth and Catastrophe: Unifying Theory and Experiment
inferredcites →https://doi.org/10.1016/j.tcb.2018.05.001openalex-snapshot
Microtubule-Targeting Agents: Strategies To Hijack the Cytoskeleton
inferredcites →https://doi.org/10.1016/j.tcb.2019.07.004openalex-snapshot
Microtubule-Associated Proteins: Structuring the Cytoskeleton
inferredcites →https://doi.org/10.1016/j.yrtph.2015.01.014openalex-snapshot
An FDA oncology analysis of antibody-drug conjugates
inferredcites →https://doi.org/10.1016/s0091-679x(10)95020-6openalex-snapshot
The Binding of Vinca Domain Agents to Tubulin
inferredcites →https://doi.org/10.1016/s0092-8674(00)80961-7openalex-snapshot
High-Resolution Model of the Microtubule
inferredcites →https://doi.org/10.1016/s0165-6147(03)00161-5openalex-snapshot
Microtubule-interacting drugs for cancer treatment
inferredcites →https://doi.org/10.1016/s1470-2045(19)30788-0openalex-snapshot
Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study
inferredcites →https://doi.org/10.1016/s2665-9913(23)00065-6openalex-snapshot
Colchicine twice a day for hand osteoarthritis (COLOR): a double-blind, randomised, placebo-controlled trial
inferredcites →https://doi.org/10.1021/acs.jmedchem.0c00629openalex-snapshot
On the Promise of Photopharmacology Using Photoswitches: A Medicinal Chemist’s Perspective
inferredcites →https://doi.org/10.1021/acs.jmedchem.1c00100openalex-snapshot
Recent Progress on Tubulin Inhibitors with Dual Targeting Capabilities for Cancer Therapy
inferredcites →https://doi.org/10.1021/acs.jmedchem.1c00413openalex-snapshot
Efficient Synthesis and Bioevaluation of Novel Dual Tubulin/Histone Deacetylase 3 Inhibitors as Potential Anticancer Agents
inferredcites →https://doi.org/10.1021/acs.jmedchem.2c00201openalex-snapshot
Designing Soluble PROTACs: Strategies and Preliminary Guidelines
inferredcites →https://doi.org/10.1021/acs.jmedchem.2c00379openalex-snapshot
Small Molecules Promote Selective Denaturation and Degradation of Tubulin Heterodimers through a Low-Barrier Hydrogen Bond
inferredcites →https://doi.org/10.1021/acs.jmedchem.2c02115openalex-snapshot
Design, Synthesis, and Biological Evaluation of Heterocyclic-Fused Pyrimidine Chemotypes Guided by X-ray Crystal Structure with Potential Antitumor and Anti-multidrug Resistance Efficacy Targeting the Colchicine Binding Site
inferredcites →https://doi.org/10.1021/acs.orglett.5b02262openalex-snapshot
Synthesis, Characterization, and Bioactivity of the Photoisomerizable Tubulin Polymerization Inhibitor azo-Combretastatin A4
inferredcites →https://doi.org/10.1021/acsmedchemlett.6b00195openalex-snapshot
Optimization of Tubulysin Antibody?Drug Conjugates: A Case Study in Addressing ADC Metabolism
inferredcites →https://doi.org/10.1021/bi00031a014openalex-snapshot
Kinetic Stabilization of Microtubule Dynamics at Steady State in Vitro by Substoichiometric Concentrations of Tubulin-Colchicine Complex
inferredcites →https://doi.org/10.1021/bi00514a041openalex-snapshot
Taxol assembles tubulin in the absence of exogenous guanosine 5'-triphosphate or microtubule-associated proteins
inferredcites →https://doi.org/10.1021/ja00738a045openalex-snapshot
Plant antitumor agents. VI. Isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia
inferredcites →https://doi.org/10.1021/ja00759a054openalex-snapshot
Tumor inhibitors. LXXIII. Maytansine, a novel antileukemic ansa macrolide from Maytenus ovatus
inferredcites →https://doi.org/10.1021/jacs.2c01020openalex-snapshot
In Vivo Photocontrol of Microtubule Dynamics and Integrity, Migration and Mitosis, by the Potent GFP-Imaging-Compatible Photoswitchable Reagents SBTubA4P and SBTub2M
inferredcites →https://doi.org/10.1021/jo00250a053openalex-snapshot
Laulimalides. New potent cytotoxic macrolides from a marine sponge and a nudibranch predator
inferredcites →https://doi.org/10.1021/jo991296yopenalex-snapshot
Peloruside A: A Potent Cytotoxic Macrolide Isolated from the New Zealand Marine Sponge Mycale sp.
inferredcites →https://doi.org/10.1023/a:1006075007857openalex-snapshot
Inhibition of apoptotic signaling pathways in cancer cells as a mechanism of chemotherapy resistance
inferredcites →https://doi.org/10.1038/34465openalex-snapshot
Structure of the αβ tubulin dimer by electron crystallography
inferredcites →https://doi.org/10.1038/embor.2008.171openalex-snapshot
Structural insight into the inhibition of tubulin by vinca domain peptide ligands
inferredcites →https://doi.org/10.1038/jid.2008.37openalex-snapshot
Microtubule-Targeted Drugs Inhibit VEGF Receptor-2 Expression by both Transcriptional and Post-Transcriptional Mechanisms
inferredcites →https://doi.org/10.1038/nature02393openalex-snapshot
Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain
inferredcites →https://doi.org/10.1038/nature03566openalex-snapshot
Structural basis for the regulation of tubulin by vinblastine
inferredcites →https://doi.org/10.1038/ncomms12103openalex-snapshot
Pironetin reacts covalently with cysteine-316 of α-tubulin to destabilize microtubule
inferredcites →https://doi.org/10.1038/ncomms15286openalex-snapshot
Kinesin-5-independent mitotic spindle assembly requires the antiparallel microtubule crosslinker Ase1 in fission yeast
inferredcites →https://doi.org/10.1038/nrc1317openalex-snapshot
Microtubules as a target for anticancer drugs
inferredcites →https://doi.org/10.1038/nrd3253openalex-snapshot
Microtubule-binding agents: a dynamic field of cancer therapeutics
inferredcites →https://doi.org/10.1038/s41388-020-1336-yopenalex-snapshot
PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics
inferredcites →https://doi.org/10.1038/s41392-022-00947-7openalex-snapshot
Antibody drug conjugate: the “biological missile” for targeted cancer therapy
inferredcites →https://doi.org/10.1038/s41392-022-00966-4openalex-snapshot
Targeted protein degradation: mechanisms, strategies and application
inferredcites →https://doi.org/10.1038/s41467-020-18389-6openalex-snapshot
Photoswitchable paclitaxel-based microtubule stabilisers allow optical control over the microtubule cytoskeleton
inferredcites →https://doi.org/10.1038/s41571-023-00736-3openalex-snapshot
Protein degraders enter the clinic — a new approach to cancer therapy
inferredcites →https://doi.org/10.1038/s41573-021-00371-6openalex-snapshot
PROTAC targeted protein degraders: the past is prologue
inferredcites →https://doi.org/10.1038/s41580-018-0009-yopenalex-snapshot
Microtubule dynamics: an interplay of biochemistry and mechanics
inferredcites →https://doi.org/10.1038/s41580-020-0214-3openalex-snapshot
The tubulin code and its role in controlling microtubule properties and functions
inferredcites →https://doi.org/10.1038/s41580-021-00399-xopenalex-snapshot
Regulation of microtubule dynamics, mechanics and function through the growing tip
inferredcites →https://doi.org/10.1039/c5ob02005kopenalex-snapshot
Photoswitchable anticancer activity via trans–cis isomerization of a combretastatin A-4 analog
inferredcites →https://doi.org/10.1039/d1cb00011jopenalex-snapshot
Proteolysis targeting chimeras (PROTACs) come of age: entering the third decade of targeted protein degradation
inferredcites →https://doi.org/10.1056/nejmoa1209124openalex-snapshot
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
inferredcites →https://doi.org/10.1056/nejmoa1814017openalex-snapshot
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
inferredcites →https://doi.org/10.1056/nejmoa2112435openalex-snapshot
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer
inferredcites →https://doi.org/10.1056/nejmoa2115304openalex-snapshot
Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma
inferredcites →https://doi.org/10.1056/nejmoa2206125openalex-snapshot
Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin’s Lymphoma
inferredcites →https://doi.org/10.1073/pnas.1408124111openalex-snapshot
A new tubulin-binding site and pharmacophore for microtubule-destabilizing anticancer drugs
inferredcites →https://doi.org/10.1073/pnas.1416418112openalex-snapshot
Microtubule-targeting agents augment the toxicity of DNA-damaging agents by disrupting intracellular trafficking of DNA repair proteins
inferredcites →https://doi.org/10.1073/pnas.2001546117openalex-snapshot
Dynamic and asymmetric fluctuations in the microtubule wall captured by high-resolution cryoelectron microscopy
inferredcites →https://doi.org/10.1073/pnas.2021847118openalex-snapshot
Gatorbulin-1, a distinct cyclodepsipeptide chemotype, targets a seventh tubulin pharmacological site
inferredcites →https://doi.org/10.1073/pnas.2114994119openalex-snapshot
Structural transitions in the GTP cap visualized by cryo-electron microscopy of catalytically inactive microtubules
inferredcites →https://doi.org/10.1073/pnas.94.18.9679openalex-snapshot
p53-independent apoptosis induced by paclitaxel through an indirect mechanism
inferredcites →https://doi.org/10.1073/pnas.95.16.9313openalex-snapshot
Antiproliferative mechanism of action of cryptophycin-52: Kinetic stabilization of microtubule dynamics by high-affinity binding to microtubule ends
inferredcites →https://doi.org/10.1074/jbc.273.9.4928openalex-snapshot
Microtubule-interfering Agents Activate c-Jun N-terminal Kinase/Stress-activated Protein Kinase through Both Ras and Apoptosis Signal-regulating Kinase Pathways
inferredcites →https://doi.org/10.1074/jbc.m113.496844openalex-snapshot
Growth Arrest by the Antitumor Steroidal Lactone Withaferin A in Human Breast Cancer Cells Is Associated with Down-regulation and Covalent Binding at Cysteine 303 of β-Tubulin
inferredcites →https://doi.org/10.1074/jbc.m901789200openalex-snapshot
Cancer Preventive Isothiocyanates Induce Selective Degradation of Cellular α- and β-Tubulins by Proteasomes
inferredcites →https://doi.org/10.1074/jbc.ra118.006325openalex-snapshot
Covalent modification of Cys-239 in β-tubulin by small molecules as a strategy to promote tubulin heterodimer degradation
inferredcites →https://doi.org/10.1074/jbc.ra119.010732openalex-snapshot
Reversible binding of the anticancer drug KXO1 (tirbanibulin) to the colchicine-binding site of β-tubulin explains KXO1's low clinical toxicity
inferredcites →https://doi.org/10.1080/02652048.2023.2188943openalex-snapshot
Co-delivery of paclitaxel and etoposide prodrug by human serum albumin and PLGA nanoparticles: synergistic cytotoxicity in brain tumour cells
inferredcites →https://doi.org/10.1080/07391102.2020.1745689openalex-snapshot
Exploring the interaction of Peloruside-A with drug resistant αβII and αβIII tubulin isotypes in human ovarian carcinoma using a molecular modeling approach
inferredcites →https://doi.org/10.1080/14656566.2016.1217991openalex-snapshot
Vinflunine for the treatment of breast cancer
inferredcites →https://doi.org/10.1080/17460441.2022.2131766openalex-snapshot
Strategies for the drug discovery and development of taxane anticancer therapeutics
inferredcites →https://doi.org/10.1083/jcb.59.2.267openalex-snapshot
MICROTUBULES: EVIDENCE FOR 13 PROTOFILAMENTS
inferredcites →https://doi.org/10.1093/abt/tbz009openalex-snapshot
Dual-mechanistic antibody-drug conjugate via site-specific selenocysteine/cysteine conjugation
inferredcites →https://doi.org/10.1093/annonc/mdw424openalex-snapshot
Antibody drug conjugates: lessons from 20 years of clinical experience
inferredcites →https://doi.org/10.1097/cad.0000000000000464openalex-snapshot
Potential anticancer role of colchicine-based derivatives
inferredcites →https://doi.org/10.1101/cshperspect.a022608openalex-snapshot
Microtubules and Microtubule-Associated Proteins
inferredcites →https://doi.org/10.1101/gad.196147.112openalex-snapshot
Dynein mediates the localization and activation of mTOR in normal and human cytomegalovirus-infected cells
inferredcites →https://doi.org/10.1111/bcp.13126openalex-snapshot
Microtubule destabilising agents: far more than just antimitotic anticancer drugs
inferredcites →https://doi.org/10.1111/boc.201300054openalex-snapshot
Mechanism and regulation of kinesin‐5, an essential motor for the mitotic spindle
inferredcites →https://doi.org/10.1111/febs.13555openalex-snapshot
Structures of a diverse set of colchicine binding site inhibitors in complex with tubulin provide a rationale for drug discovery
inferredcites →https://doi.org/10.1124/mol.106.027847openalex-snapshot
Synergistic Effects of Peloruside A and Laulimalide with Taxoid Site Drugs, but Not with Each Other, on Tubulin Assembly
inferredcites →https://doi.org/10.1126/sciadv.abg4168openalex-snapshot
Cevipabulin-tubulin complex reveals a novel agent binding site on α-tubulin with tubulin degradation effect
inferredcites →https://doi.org/10.1126/science.1230582openalex-snapshot
Molecular Mechanism of Action of Microtubule-Stabilizing Anticancer Agents
inferredcites →https://doi.org/10.1136/ard.13.3.190openalex-snapshot
History of the Use of Colchicum and related Medicaments in Gout
inferredcites →https://doi.org/10.1155/2018/8956072openalex-snapshot
Microtubule-Associated Protein 4 Is a Prognostic Factor and Promotes Tumor Progression in Lung Adenocarcinoma
inferredcites →https://doi.org/10.1155/2022/1623181openalex-snapshot
Microtubule Organization Is Essential for Maintaining Cellular Morphology and Function
inferredcites →https://doi.org/10.1158/0008-5472.can-04-0771openalex-snapshot
Peloruside A Does Not Bind to the Taxoid Site on β-Tubulin and Retains Its Activity in Multidrug-Resistant Cell Lines
inferredcites →https://doi.org/10.1158/0008-5472.can-12-3256openalex-snapshot
Cytotoxic Activity of Tivantinib (ARQ 197) Is Not Due Solely to c-MET Inhibition
inferredcites →https://doi.org/10.1158/0008-5472.can-15-1313openalex-snapshot
Enfortumab Vedotin Antibody–Drug Conjugate Targeting Nectin-4 Is a Highly Potent Therapeutic Agent in Multiple Preclinical Cancer Models
inferredcites →https://doi.org/10.1158/1078-0432.ccr-11-0488openalex-snapshot
Brentuximab Vedotin (SGN-35)
inferredcites →https://doi.org/10.1158/1535-7163.mct-11-0614openalex-snapshot
βII-Tubulin and βIII-Tubulin Mediate Sensitivity to Peloruside A and Laulimalide, but not Paclitaxel or Vinblastine, in Human Ovarian Carcinoma Cells
inferredcites →https://doi.org/10.1158/1535-7163.mct-13-0791openalex-snapshot
Targeting Microtubules by Natural Agents for Cancer Therapy
inferredcites →https://doi.org/10.1158/1541-7786.mcr-05-0183openalex-snapshot
Regulation of Class II β-Tubulin Expression by Tumor Suppressor p53 Protein in Mouse Melanoma Cells in Response toVincaAlkaloid
inferredcites →https://doi.org/10.1161/circulationaha.121.056171openalex-snapshot
Colchicine in Cardiovascular Disease: In-Depth Review.
inferredcites →https://doi.org/10.1177/1078155214527144openalex-snapshot
Ado-trastuzumab emtansine (T-DM1): a novel antibody-drug conjugate for the treatment of HER2-positive metastatic breast cancer
inferredcites →https://doi.org/10.1177/1535370219867296openalex-snapshot
Microtubules: Evolving roles and critical cellular interactions
inferredcites →https://doi.org/10.1177/1756287216677903openalex-snapshot
Vinflunine in the treatment of advanced urothelial cancer: clinical evidence and experience
inferredcites →https://doi.org/10.1186/s12931-017-0544-7openalex-snapshot
The roles and regulation of the actin cytoskeleton, intermediate filaments and microtubules in smooth muscle cell migration
inferredcites →https://doi.org/10.1186/s12935-022-02624-9openalex-snapshot
Anticancer potential of alkaloids: a key emphasis to colchicine, vinblastine, vincristine, vindesine, vinorelbine and vincamine
inferredcites →https://doi.org/10.1186/s12943-021-01434-3openalex-snapshot
Proteolysis-targeting chimeras (PROTACs) in cancer therapy
inferredcites →https://doi.org/10.1186/s13045-021-01097-zopenalex-snapshot
Antibody-drug conjugates for the treatment of lymphoma: clinical advances and latest progress
inferredcites →https://doi.org/10.1186/s13045-021-01098-yopenalex-snapshot
A dual inhibitor overcomes drug-resistant FLT3-ITD acute myeloid leukemia
inferredcites →https://doi.org/10.1200/jco.19.00172openalex-snapshot
Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
inferredcites →https://doi.org/10.1200/jco.22.01900openalex-snapshot
Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study
inferredcites →https://doi.org/10.1242/jcs.115.1.3openalex-snapshot
Microtubule dynamics
inferredcites →https://doi.org/10.1242/jcs.259539openalex-snapshot
Tubulin isotypes – functional insights from model organisms
inferredcites →https://doi.org/10.1248/cpb.52.1openalex-snapshot
Recent Developments in the Maytansinoid Antitumor Agents
inferredcites →https://doi.org/10.1371/journal.pone.0160890openalex-snapshot
Structural Basis of Microtubule Destabilization by Potent Auristatin Anti-Mitotics
inferredcites →https://doi.org/10.1517/14740331003774078openalex-snapshot
Vinorelbine for non-small cell lung cancer
inferredcites →https://doi.org/10.20517/cdr.2019.06openalex-snapshot
Resistance to anti-tubulin agents: From vinca alkaloids to epothilones
inferredcites →https://doi.org/10.2147/cmar.s150960openalex-snapshot
Comparative effectiveness of early-line nab-paclitaxel vs. paclitaxel in patients with metastatic breast cancer: a US community-based real-world analysis
inferredcites →https://doi.org/10.2147/dddt.s28997openalex-snapshot
Update on taxane development: new analogs and new formulations
inferredcites →https://doi.org/10.2147/ott.s370900openalex-snapshot
Targeted Treatment of Locally Advanced and Metastatic Urothelial Cancer: Enfortumab Vedotin in Context
inferredcites →https://doi.org/10.2174/0929867327666200316144610openalex-snapshot
Tubulin Maytansine Site Binding Ligands and their Applications as MTAs and ADCs for Cancer Therapy
inferredcites →https://doi.org/10.2217/fon-2017-0379openalex-snapshot
A Review of Mirvetuximab Soravtansine in the Treatment of Platinum-Resistant Ovarian Cancer
inferredcites →https://doi.org/10.2478/aiht-2019-70-3258openalex-snapshot
An overview of microtubule targeting agents for cancer therapy
inferredcites →https://doi.org/10.3389/fmolb.2022.841777openalex-snapshot
Recent Approaches to the Identification of Novel Microtubule-Targeting Agents
inferredcites →https://doi.org/10.3389/fonc.2021.680402openalex-snapshot
Expression of Microtubule-Associated Proteins in Relation to Prognosis and Efficacy of Immunotherapy in Non-Small Cell Lung Cancer
inferredcites →https://doi.org/10.3389/fonc.2021.684561openalex-snapshot
Mechanisms of Action of the New Antibodies in Use in Multiple Myeloma
inferredcites →https://doi.org/10.3389/fphar.2022.935493openalex-snapshot
Emerging role of microtubule-associated proteins on cancer metastasis
inferredcites →https://doi.org/10.3389/fpls.2014.00511openalex-snapshot
The role of dynamic instability in microtubule organization
inferredcites →https://doi.org/10.3390/biology12040561openalex-snapshot
Tubulin Post-Translational Modifications: The Elusive Roles of Acetylation
inferredcites →https://doi.org/10.3390/biomedicines9080872openalex-snapshot
Advances and Limitations of Antibody Drug Conjugates for Cancer
inferredcites →https://doi.org/10.3390/cancers12030630openalex-snapshot
Role of Microtubule-Associated Protein 1b in Urothelial Carcinoma: Overexpression Predicts Poor Prognosis
inferredcites →https://doi.org/10.3390/cancers13225650openalex-snapshot
Microtubule Targeting Agents in Disease: Classic Drugs, Novel Roles
inferredcites →https://doi.org/10.3390/cancers15030636openalex-snapshot
Tumor Treating Fields (TTFields) Therapy Concomitant with Taxanes for Cancer Treatment
inferredcites →https://doi.org/10.3390/cells8040346openalex-snapshot
Regulating the BCL2 Family to Improve Sensitivity to Microtubule Targeting Agents
inferredcites →https://doi.org/10.3390/cells9051083openalex-snapshot
Tubulin Resists Degradation by Cereblon-Recruiting PROTACs
inferredcites →https://doi.org/10.3390/cells9112356openalex-snapshot
The Tubulin Code in Mitosis and Cancer
inferredcites →https://doi.org/10.3390/ijms18081733openalex-snapshot
Taxol®: The First Microtubule Stabilizing Agent
inferredcites →https://doi.org/10.3390/ijms22137053openalex-snapshot
Combinatorial Treatment of Tinzaparin and Chemotherapy Can Induce a Significant Antitumor Effect in Pancreatic Cancer
inferredcites →https://doi.org/10.3390/ijms23105657openalex-snapshot
Photopharmacology of Antimitotic Agents
inferredcites →https://doi.org/10.3390/ijms24065190openalex-snapshot
Emerging Strategies in Proteolysis-Targeting Chimeras (PROTACs): Highlights from 2022
inferredcites →https://doi.org/10.3390/molecules21111468openalex-snapshot
Current Advances of Tubulin Inhibitors in Nanoparticle Drug Delivery and Vascular Disruption/Angiogenesis
inferredcites →https://doi.org/10.3390/molecules22081281openalex-snapshot
Tubulin Inhibitor-Based Antibody-Drug Conjugates for Cancer Therapy
inferredcites →https://doi.org/10.3390/molecules26195847openalex-snapshot
An Insight into FDA Approved Antibody-Drug Conjugates for Cancer Therapy
inferredcites →https://doi.org/10.3390/ph13090245openalex-snapshot
Antibody–Drug Conjugates: The Last Decade
inferredcites →https://doi.org/10.3390/pharmaceutics13101705openalex-snapshot
Antibody-Antineoplastic Conjugates in Gynecological Malignancies: Current Status and Future Perspectives
inferredcites →https://doi.org/10.4172/2157-7439.1000164openalex-snapshot
Paclitaxel Nano-Delivery Systems: A Comprehensive Review
inferredcites →https://doi.org/10.7164/antibiotics.47.697openalex-snapshot
Pironetin, a novel plant growth regulator produced by Streptomyces sp. NK 10958. I. Taxonomy, production, isolation and preliminary characterization.
inferredcites →https://doi.org/10.7164/antibiotics.48.893openalex-snapshot
Azalomycin F Complex from Streptomyces hygroscopicus ,MSU/MN-4-75B.
inferredcites →https://doi.org/10.7554/elife.51992openalex-snapshot
The speed of GTP hydrolysis determines GTP cap size and controls microtubule stability
inferredcites →https://doi.org/10.7554/elife.84791openalex-snapshot
Structural insight into the stabilization of microtubules by taxanes

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4641581openalex-extracted
inferred← citeshttps://doi.org/10.1002/ardp.70031openalex-snapshot
Isoxazole‐Based Compounds Targeting the Taxane‐Binding Site of Tubulin
inferred← citeshttps://doi.org/10.1002/ardp.70087openalex-snapshot
Synthesis, Identification, and Characterization of a Novel 1,2,5‐Selenadiazole Derivative as a Microtubule Targeting Agent That Overcomes Multidrug Resistance
inferred← citeshttps://doi.org/10.1002/ardp.70104openalex-snapshot
In Vitro Modeling of the Antitumor Drugs Effects on the Endothelial Barrier Function
inferred← citeshttps://doi.org/10.1002/cam4.71802openalex-snapshot
Biopharmaceuticals for Cancer Treatment: An Update
inferred← citeshttps://doi.org/10.1002/cmdc.202300527openalex-snapshot
Synthesis, characterization of novel N‐(4‐cyano‐1,3‐oxazol‐5‐yl)sulfonamide derivatives and in vitro screening their activity against NCI‐60 cancer cell lines
inferred← citeshttps://doi.org/10.1002/cmdc.202500320openalex-snapshot
Unveiling Benzoxazole‐Substituted Thiazolyl‐Pyrazole Derivatives Inducing Apoptosis by Targeting β‐Tubulin and Caspase‐3
inferred← citeshttps://doi.org/10.1002/cmdc.70456openalex-snapshot
Design and Synthesis of Combretastatin A4‐Chalcone Hybrids as Tubulin Polymerization Inhibitors
inferred← citeshttps://doi.org/10.1002/slct.202502546openalex-snapshot
High‐Performance Epothilone‐Based Microtubule Stabilizers as Anticancer Agents: Insights from DFT/QTAIM/MD Computational Modeling
inferred← citeshttps://doi.org/10.1007/978-3-032-19668-2_7openalex-snapshot
Mechanistic Role of Long Non-coding RNAs in Drug and Radiotherapy Resistance of Cancer Cells
inferred← citeshttps://doi.org/10.1007/s00018-024-05565-wopenalex-snapshot
Microtubule acetylation and PERK activation facilitate eribulin-induced mitochondrial calcium accumulation and cell death
inferred← citeshttps://doi.org/10.1007/s00044-025-03517-yopenalex-snapshot
Design and synthesis of Cereblon-based PROTAC as novel potent degraders of α/β-tubulin
inferred← citeshttps://doi.org/10.1007/s00044-026-03607-5openalex-snapshot
Indole-based derivatives as anticancer agents: recent advances in structure–activity relationships and biological mechanisms
inferred← citeshttps://doi.org/10.1007/s11030-026-11594-3openalex-snapshot
Recent advancements in microtubule targeting agents for breast cancer: design strategies and pharmacological insights
inferred← citeshttps://doi.org/10.1007/s40495-026-00476-9openalex-snapshot
Bispecific Antibody-Drug Conjugates in Oncology: Design Principles, Clinical Progress, and Challenges
inferred← citeshttps://doi.org/10.1007/s44345-026-00047-xopenalex-snapshot
Oscillatory dynamics in paclitaxel-proteinoid networks
inferred← citeshttps://doi.org/10.1016/b978-0-443-13827-0.00017-2openalex-snapshot
TGF-β in tumor microenvironment, metabolism, and immunotherapy
inferred← citeshttps://doi.org/10.1016/b978-0-443-21790-6.00005-5openalex-snapshot
Altered cell cycle regulation in the development of resistance
inferred← citeshttps://doi.org/10.1016/b978-0-443-45380-9.00001-8openalex-snapshot
Ethical and clinical implications of sirtuin therapies
inferred← citeshttps://doi.org/10.1016/bs.apcsb.2025.10.014openalex-snapshot
Biosimilars: Antibody and nanobody-based therapeutic approaches towards protein misfolding diseases
inferred← citeshttps://doi.org/10.1016/j.bbrc.2025.152245openalex-snapshot
Structure of quercetin 3,4′-dimethyl ether in complex with tubulin provides a rationale for drug design
inferred← citeshttps://doi.org/10.1016/j.bbrc.2025.153019openalex-snapshot
Current advancements in tubulin targeting agents for breast cancer: Design strategies, structure-activity relationships, and pharmacological insights
inferred← citeshttps://doi.org/10.1016/j.bcp.2025.117063openalex-snapshot
Synthetic homoisoflavane derivatives suppress the growth of colorectal cancer cells by disturbing microtubule dynamics
inferred← citeshttps://doi.org/10.1016/j.bioorg.2024.107299openalex-snapshot
Design, synthesis and biological evaluation of new 2,6-difluorinated phenyl 4-(2-oxoimidazolidin-1-yl)benzenesulfonates as new antimicrotubule agents
inferred← citeshttps://doi.org/10.1016/j.bioorg.2024.107569openalex-snapshot
The cytotoxic natural compound erianin binds to colchicine site of β-tubulin and overcomes taxane resistance
inferred← citeshttps://doi.org/10.1016/j.bioorg.2024.107827openalex-snapshot
Unveiling the anti-cancer potentiality of phthalimide-based Analogues targeting tubulin polymerization in MCF-7 cancerous Cells: Rational design, chemical Synthesis, and Biological-coupled Computational investigation
inferred← citeshttps://doi.org/10.1016/j.bioorg.2024.107920openalex-snapshot
Molecular tweaking by generative cheminformatics and ligand–protein structures for rational drug discovery
inferred← citeshttps://doi.org/10.1016/j.bioorg.2026.109517openalex-snapshot
An insight into the anticancer potential of sulfonated styrylquinazolines as multifunctional agents targeting microtubules.
inferred← citeshttps://doi.org/10.1016/j.bioorg.2026.109615openalex-snapshot
Strategic engineering of imidazopyridine-benzoxazole hybrids targeting microtubule dynamics: comprehensive inhibition of the metastatic cascade
inferred← citeshttps://doi.org/10.1016/j.bmc.2025.118488openalex-snapshot
Repurposing the USFDA-approved small molecules for their affinity against the colchicine binding site (CBS) in the tubulin: Corroborating the in-silico findings through biological assessment
inferred← citeshttps://doi.org/10.1016/j.bmc.2026.118587openalex-snapshot
Machine learning-driven computational drug repurposing to identify new tubulin inhibitors against cancer
inferred← citeshttps://doi.org/10.1016/j.bmcl.2024.130037openalex-snapshot
Recent advances of selenized tubulin inhibitors in cancer therapy
inferred← citeshttps://doi.org/10.1016/j.bmcl.2025.130284openalex-snapshot
Discovery of novel coumarin-sulfonates as tubulin polymerization inhibitors targeting the colchicine-binding site with potent anticancer activities
inferred← citeshttps://doi.org/10.1016/j.canlet.2026.218844openalex-snapshot
Therapeutic potential of colchicine-binding site inhibitors in breast cancer brain metastasis
inferred← citeshttps://doi.org/10.1016/j.carres.2026.110053openalex-snapshot
Design, synthesis, in vitro anticancer evaluation, in silico molecular docking and ADMET profiling of carbohydrate-conjugated pyridine oximes
inferred← citeshttps://doi.org/10.1016/j.ejmech.2024.117058openalex-snapshot
Synthesis, biological evaluation and mechanism study of a novel indole-pyridine chalcone derivative as antiproliferative agent against tumor cells through dual targeting tubulin and HK2
inferred← citeshttps://doi.org/10.1016/j.ejmech.2025.117314openalex-snapshot
Discovery of novel thienopyridine indole derivatives as inhibitors of tubulin polymerization targeting the colchicine-binding site with potent anticancer activities
inferred← citeshttps://doi.org/10.1016/j.ejmech.2025.117879openalex-snapshot
Discovery of novel 1,2,3-triazole arylamide derivatives bearing dithiocarbamate moiety as dual inhibitors of tubulin and LSD1 with potent anticancer activity
inferred← citeshttps://doi.org/10.1016/j.ejmech.2026.118658openalex-snapshot
Marine natural product-inspired 2-(3,4,5-trimethoxybenzoyl)quinazolin-4(3H)-one derivative CHNQD-01522: A novel anti-hepatocellular carcinoma agent targeting colchicine binding site of microtubule
inferred← citeshttps://doi.org/10.1016/j.jddst.2024.106007openalex-snapshot
Implications of nanotherapeutic advancements to leverage multi-drug resistant breast cancer: The state-of-the-art review
inferred← citeshttps://doi.org/10.1016/j.jep.2025.120034openalex-snapshot
A review on the microtubule inhibitory effects of active ingredients extracted from TCMs and ethnic medicines in cancer treatment
inferred← citeshttps://doi.org/10.1016/j.jncc.2025.01.007openalex-snapshot
Advancements in antibody-drug conjugates as cancer therapeutics
inferred← citeshttps://doi.org/10.1016/j.lfs.2025.123644openalex-snapshot
A novel tubulin inhibitor, No.07, shows anti-cancer and anti-metastatic effects in colon cancer and tumoroids
inferred← citeshttps://doi.org/10.1016/j.molstruc.2026.147688openalex-snapshot
Synthesis and structural characterization of squaric acid derivatives containing 3,4,5-trimethoxyphenyl; crystal structures and preliminary biological evaluation
inferred← citeshttps://doi.org/10.1016/j.sbi.2024.102845openalex-snapshot
Structure-based discovery and rational design of microtubule-targeting agents
inferred← citeshttps://doi.org/10.1016/j.tet.2024.134350openalex-snapshot
Drug-linker constructs bearing unique dual-mechanism tubulin binding payloads tethered through cleavable and non-cleavable linkers
inferred← citeshttps://doi.org/10.1016/j.tice.2026.103314openalex-snapshot
Efficacy of pumpkin seed oil on paclitaxel-induced tongue mucosal injury in rat: Structural and biochemical insights
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5c02701openalex-snapshot
Tubulin Zone Occupancy by PDB-Deposited Colchicine Binding Site Inhibitors
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.6c00216openalex-snapshot
Discovery of the First Highly Potent and Selective Peptide Inhibitor Targeting Microtubule-MAP7 Interaction via Structure-Based Design for Suppressing Colorectal Cancer Cell Proliferation
inferred← citeshttps://doi.org/10.1021/acsami.5c07808openalex-snapshot
TUBB3/DTX LNPs Dry Powder Inhaler and an Efficient Delivery Device for Targeted Therapy of Lung Cancer
inferred← citeshttps://doi.org/10.1021/acsanm.5c05508openalex-snapshot
Ergotamine-Loaded Nanoparticles for Targeting Microtubule Dynamics in Triple-Negative Breast Cancer Cells
inferred← citeshttps://doi.org/10.1021/acsomega.5c10113openalex-snapshot
Novel Imidazopyridine–Oxadiazole β-Tubulin Inhibitors Suppress Breast Cancer Migration and Induce Caspase-3-Mediated Apoptosis
inferred← citeshttps://doi.org/10.1021/acsomega.6c05137openalex-snapshot
Elucidating the Covalent Binding of Ottelione A and Withaferin A at the Colchicine Site of β-Tubulin
inferred← citeshttps://doi.org/10.1021/acsomega.6c05272openalex-snapshot
Overcoming Docetaxel Resistance in Prostate Cancer by Targeting Cell Cycle Progression with Narciclasine-Based Compounds
inferred← citeshttps://doi.org/10.1021/jacs.4c11820openalex-snapshot
Microtubule-Targeting NAP Peptide-Ru(II)-polypyridyl Conjugate As a Bimodal Therapeutic Agent for Triple Negative Breast Carcinoma
inferred← citeshttps://doi.org/10.1039/d4tb02445aopenalex-snapshot
Organ-targeted drug delivery systems (OTDDS) of poly[( N -acryloylglycine)- co -( N -acryloyl- l -phenylalanine methyl ester)] copolymer library and effective treatment of triple-negative breast cancer
inferred← citeshttps://doi.org/10.1039/d5cb00321kopenalex-snapshot
Illuminating microtubule functions with small molecules: past, present and future of fluorescent tubulin-binding probes
inferred← citeshttps://doi.org/10.1073/pnas.2424098122openalex-snapshot
Identification of a ligand-binding site on tubulin mediating the tubulin–RB3 interaction
inferred← citeshttps://doi.org/10.1080/07391102.2024.2306493openalex-snapshot
Design of novel isoxazole derivatives as tubulin inhibitors using computer-aided techniques: QSAR modeling, in silico ADMETox, molecular docking, molecular dynamics, biological efficacy, and retrosynthesis
inferred← citeshttps://doi.org/10.1080/1061186x.2025.2573063openalex-snapshot
Targeting glioblastoma with hybrid H 3 R antagonists with piperidinylpropoxy and trimethoxychalcone motifs results in broad oncosuppressive effects
inferred← citeshttps://doi.org/10.1080/14656566.2024.2369196openalex-snapshot
Updates in pharmacotherapy for non-small cell lung cancer: a focus on emerging tubulin inhibitors
inferred← citeshttps://doi.org/10.1080/17568919.2025.2546774openalex-snapshot
Tubulin inhibitors: an insight into new strategies to combat leukemia
inferred← citeshttps://doi.org/10.1111/bph.70294openalex-snapshot
Anti‐mitotic agent SB‐216 overcomes taxane resistance in castration‐resistant prostate cancer and exhibits anti‐tumour efficacy in pancreatic cancer
inferred← citeshttps://doi.org/10.1158/1535-7163.mct-24-1208openalex-snapshot
RGN6024 Is a Brain-Penetrant, Small-Molecule Tubulin Destabilizer for the Treatment of Glioblastoma
inferred← citeshttps://doi.org/10.1177/00220345241261982openalex-snapshot
Novel Antimitotic Agent SP-1-39 Inhibits Head and Neck Squamous Cell Carcinoma
inferred← citeshttps://doi.org/10.1186/s40164-024-00591-7openalex-snapshot
Biomechanics in the tumor microenvironment: from biological functions to potential clinical applications
inferred← citeshttps://doi.org/10.12991/jrespharm.1695512openalex-snapshot
In silico analysis of tubulin self-assembly inhibition and pharmaceutical profiling of novel vinca alkaloid derivatives
inferred← citeshttps://doi.org/10.1371/journal.pone.0319415openalex-snapshot
Design, synthesis, and in vitro evaluation of a carbamazepine derivative with antitumor potential in a model of Acute Lymphoblastic Leukemia
inferred← citeshttps://doi.org/10.1371/journal.pone.0327621openalex-snapshot
Computational discovery of potential therapeutic agents against brain-eating amoeba (Naegleria fowleri)
inferred← citeshttps://doi.org/10.1371/journal.pone.0344658openalex-snapshot
Comparison of the effects of different types of treatment protocols on the median and overall survival rates of non-small cell lung cancer patients: A real-world retrospective study
inferred← citeshttps://doi.org/10.2147/btt.s484068openalex-snapshot
Herbal Therapies for Cancer Treatment: A Review of Phytotherapeutic Efficacy
inferred← citeshttps://doi.org/10.2147/dddt.s562135openalex-snapshot
Tumor Targeting with Peptide-Drug Conjugates: Showcasing Key Progress and Hurdles
inferred← citeshttps://doi.org/10.30827/ars.v66i4.33781openalex-snapshot
Aplicaciones de la Fotofarmacología en Oncología: Una Revisión del Estado del Arte
inferred← citeshttps://doi.org/10.33263/lianbs152.071openalex-snapshot
Deciphering the Pivotal Role of Nanoformulations of Vinca Alkaloids in Cancer: Preclinical, Clinical, and Patent Status
inferred← citeshttps://doi.org/10.3389/fbiom.2025.1544465openalex-snapshot
Vaccine adjuvants for immunotherapy: type, mechanisms and clinical applications
inferred← citeshttps://doi.org/10.3389/fimmu.2025.1678907openalex-snapshot
Antibody-drug conjugates as immuno-oncology agents in colorectal cancer: targets, payloads, and therapeutic synergies
inferred← citeshttps://doi.org/10.3389/fmed.2025.1698177openalex-snapshot
Mechanical stress-mediated immune and inflammatory regulation: a bibliometric and visualization analysis of mechanoimmunology based on two databases
inferred← citeshttps://doi.org/10.3389/fmolb.2026.1778506openalex-snapshot
TUBB2A expression and its prognostic significance in hepatocellular carcinoma revealed by cholesterol-metabolism-related gene profiling
inferred← citeshttps://doi.org/10.3389/fphar.2026.1779469openalex-snapshot
The therapeutic potential of colchicine in oncology studies: from structural modification and targeted delivery to clinical management
inferred← citeshttps://doi.org/10.3390/cancers17081378openalex-snapshot
Interplay Between the Cytoskeleton and DNA Damage Response in Cancer Progression
inferred← citeshttps://doi.org/10.3390/cancers17111792openalex-snapshot
Advancing Antibody–Drug Conjugates: Precision Oncology Approaches for Breast and Pancreatic Cancers
inferred← citeshttps://doi.org/10.3390/ijms25031691openalex-snapshot
BP-M345 as a Basis for the Discovery of New Diarylpentanoids with Promising Antimitotic Activity
inferred← citeshttps://doi.org/10.3390/ijms25115704openalex-snapshot
Identification of 3-Aryl-1-benzotriazole-1-yl-acrylonitrile as a Microtubule-Targeting Agent (MTA) in Solid Tumors
inferred← citeshttps://doi.org/10.3390/ijms252212301openalex-snapshot
TBCC Domain-Containing Protein Regulates Sporulation and Virulence of Phytophthora capsici via Nutrient-Responsive Signaling
inferred← citeshttps://doi.org/10.3390/md23060233openalex-snapshot
Cyanobacterial Peptides in Anticancer Therapy: A Comprehensive Review of Mechanisms, Clinical Advances, and Biotechnological Innovation
inferred← citeshttps://doi.org/10.3390/molecules30163314openalex-snapshot
Recent Advances in Microtubule Targeting Agents for Cancer Therapy
inferred← citeshttps://doi.org/10.3390/ph18010072openalex-snapshot
From Infection to Tumor: Exploring the Therapeutic Potential of Ciprofloxacin Derivatives as Anticancer Agents
inferred← citeshttps://doi.org/10.3390/pharmaceutics18091064openalex-snapshot
Small Molecule Drug Conjugate Hybrids of Naphthalene Sulfonamide and Phospholipid Conjugates Are Microtubule-Disrupting Antitumor Agents
inferred← citeshttps://doi.org/10.52711/0974-360x.2026.00282openalex-snapshot
Selectivity Index Profile of Taxus sumatrana (Miq.) de Laub. Extracts in Breast and Cervical Cancer Cells
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.